Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

13Nov

Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

Portfolio News
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 12:35 PM EST. Read more >>

Share this post

Related Posts

17Oct

Aircuity Celebrates National Energy Awareness Month

Aircuity (www.aircuity.com), the indoor air quality company, today celebrated National Energy Awareness Month by recognizing the work done by Aircuity's... read more
31Mar

Airey family seeks funding help for blind son

Andrew wrote that he tried eSight Eyewear’s electronic glasses and could see a world he never thought he’d be able... read more
06Jan

Myomo to Present H.C. Wainwright Virtual BioConnect 2021 Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
20Mar

The World’s Most Innovative Companies of 2024

Candidly on the list. Read more >> read more
24Feb

Embrace the boom at Silver Economy Summit

On March 6 and 7, the Department of Seniors and the Halifax Chamber of Commerce are presenting the fourth Annual... read more
14Aug

Kalion Inc. Receives NSF Phase II SBIR Grant to Develop Bio-based Glucaric Acid

Kalion Inc. has been awarded a National Science Foundation (NSF) Phase II Small Business Research (SBIR) grant for $746,822 to... read more
16Jul

The 24 Best Canned Wine Releases of 2022

The canned wine market is being pulled in different directions. One way is chock full of affordable, mass-produced, widely available... read more
13Feb

BrandVerge Appoints Leaders from Twitter and Wavemaker to Advisory Board

BrandVerge, a premium advertising marketplace for media buyers and sellers, today announced several Advisory Board appointments, including Carl Fremont, President... read more
10Jan

Corbus Pharma’s IND Application Gets FDA Clearance For Investigational Drug CRB-601

Corbus Pharmaceuticals Holdings, Inc.  Tuesday announced FDA clearance for its investigational new drug or IND application of CRB-601, a TGFß... read more
14Mar

Myomo Reports Fourth Quarter and Full Year 2022 Financial Result

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more